Table 3.
Thin prep and HPV(+) testing by HC2 or PCR versus biopsy
| Biopsy results | |||||||
|---|---|---|---|---|---|---|---|
| WNL | CIN 1¶ | CIN 2 | CIN 3 | SCC | AdenoCa | ||
| ThinPrep | Total | ||||||
| WNL (HPV pos) # | 181 | 4 | 0 | 0 | 0 | 0 | 185 |
| ASCUS | 40 | 58 | 2 | 0 | 1 | 0 | 101 |
| LSIL | 0 | 117 | 2 | 0 | 0 | 0 | 119 |
| HSIL | 0 | 0 | 7 | 3 | 0 | 0 | 10 |
| SCC | 0 | 0 | 0 | 0 | 10 | 0 | 10 |
| AdenoCa | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Total | 221 | 179 | 11 | 3 | 11 | 1 | 426# |
| HPV test-HC2 | WNL | CIN 1¶ | CIN 2 | CIN 3 | SCC | AdenoCa | Total |
| HC2 + | 104 | 137 | 8 | 2 | 9 | 0 | 260 |
| Negative | 959 | 44 | 3 | 1 | 2 | 1 | 1010 |
| Total | 1063 | 181 | 11 | 3 | 11 | 1 | 1270 |
| (+) HPV test-PCR | WNL | CIN 1 | CIN 2 | CIN 3 | SCC | AdenoCa | Total |
| HPV X | 180 | 46 | 1 | 0 | 0 | 0 | 227 |
| HPV 6 | 10 | 12 | 2 | 0 | 0 | 0 | 24 |
| HPV 11 | 1 | 24 | 2 | 0 | 0 | 0 | 27 |
| HPV 16 | 0 | 4 | (3*) | (3*) | 6 (4*) | 0 | 10 |
| HPV 18 | 0 | 13 | (6*) | 0 | 1 (3*) | 1 | 15 |
| HPV 31 | 0 | 4 | (1*) | (1*) | (2*) | 0 | 4 |
| HPV 33 | 10 | 0 | (1*) | (1*) | (3*) | 0 | 10 |
| Multiple HPV types | 7 | 60 | 6 | 3 | 4 | 0 | 80 |
| PCR (-) | 855 | 18 | 0 | 0 | 0 | 0 | 873 |
| Total | 1063 | 181 | 11 | 3 | 11 | 1 | 1270 |
# Data on 844 women with Thin test within normal limits and no HPV detection or colposcopic lesion that did not undergo biopsy are not shown.
¶2 Two women had a colposcopic lesion that on biopsy was CIN 1, with normal pap and no HPV
* Denotes the presence of mixed infections that are summarized under multiple HPV types. All multiple infections associated with > = CIN2 had either HPV 16, 18, 31, 33.